Enable more effective and targeted treatments that address unique needs for patients with pharmacogenomics. The traditional one-size-fits-all approach to medication has long been recognized as a ...

For patients with noncardioembolic ischemic stroke or high-risk transient ischemic attack, asundexian, a factor XIa inhibitor ...

BLOOM (TAMPA) – Dr. Dawn Ann Molina, DAOM, LAc., a quadruple Board-Certified Primary Care Physician specializing in Lifestyle Disease Prevention, joined Gayle Guyardo on the global health and wellness ...

Prof. Dragan Primorac, President of ISABS, emphasized the significance of the event, said: “Artificial intelligence is not just a tool; it represents a paradigm shift in medicine. By integrating AI ...

Forbes contributors publish independent expert analyses and insights. Juergen Eckhardt leads Bayer’s impact investment unit, Leaps by Bayer. Some of the year's notable breakthroughs include the first ...

This Research Topic is part of the series of " Public Health Promotion and Medical Education Reform":Public Health Promotion and Medical Education Reform, ...

The 14th ISABS and Mayo Clinic Conference will showcase how artificial intelligence is transforming precision medicine, June 15–19, 2026 NY, UNITED STATES, January ...